FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081328 [Registered on: 25/02/2025] Trial Registered Prospectively
Last Modified On: 22/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Therapeutic]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison between Rasapachak vati and Sahacharadi Tail Basti and Oral contraceptive pills and Metformin in PCOD patients  
Scientific Title of Study   Evaluation of comparative Efficacy of combination of Rasapachak Vati with Sahacharadi tail Basti versus Oral contraceptive pills along With Metformin on ovarian Morphology in patients of Polycystic ovarian syndrome -A Randomised Control Trial  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vidya Bhaskarrao Dole  
Designation  Assistant Professor  
Affiliation  Govt Ayurved College, Vajirabad 
Address  Department of Rachana Sharir,Govt Ayurved College Vajirabad, Nanded.
Department of Stri-roga and Prasuti Tantra, OPD No. 13, Govt Ayurved College Vajirabad, Nanded
Nanded
MAHARASHTRA
431601
India 
Phone  07083434569  
Fax    
Email  drvidyadole@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Gaurav Sawarkar 
Designation  Professor 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Centre,  
Address  Department of Rachana Sharir, Mahatma Gandhi Ayurved College Hospital and Research Centre,Salod(H), Sawangi (Meghe), Wardha

Wardha
MAHARASHTRA
442004
India 
Phone  9970082590  
Fax    
Email  drsawarkar.gaurav@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gaurav Sawarkar 
Designation  Professor 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Centre,  
Address  Department of Rachana Sharir, Mahatma Gandhi Ayurved College Hospital and Research Centre,Salod(H), Sawangi (Meghe), Wardha

Wardha
MAHARASHTRA
442004
India 
Phone  9970082590  
Fax    
Email  drsawarkar.gaurav@gmail.com  
 
Source of Monetary or Material Support  
Department of Striroga and Prasuti Tantra, OPD No.13, Government Ayurved College, Nanded, Maharashtra- 431601, India 
 
Primary Sponsor  
Name  Dr Vidya Bhaskarrao Dole 
Address  Department of Rachana Sharir, Govt. Ayurved College, & Hospital Vajirabad Nanded, Maharashtra -431601, India 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vidya Dole  Govt. Ayurved College And Hospital,   Department of Stri-roga and Prasuti Tantra, OPD No.13, Govt. Ayurved College and Hospital, Nanded Vajirabad.
Nanded
MAHARASHTRA 
07083434569

drvidyadole@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Govt Ayurved College Nanded  Approved 
Mahatma Gandhi Ayurved College, Hospital and Research centre, Salod (H), Wardha, Maharashtra-442001  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N832||Other and unspecified ovarian cysts. Ayurveda Condition: RASAVAHASROTODUSHTIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Rasapachak Vati, Reference: Ch. Chi. 3/200, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Patients fulfilling the Rotterdam 2003 criteria for diagnosis. 
 
ExclusionCriteria 
Details  - Patient suffering from gynecological disorder other than PCOS.
- History of hypersensitivity to OC Pills.
- Patient suffering from any systemic chronic illness.
- Patients on hormonal therapy
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Number of cysts in ovary, Ovarian size & volume, Anthropometric parameters will be reduced.  Reduction in Number of cysts, Ovarian size & volume, Anthropometric parameters will be assessed at 0th day and 120th day of follow up.  
 
Secondary Outcome  
Outcome  TimePoints 
1)To understand the changes in ovarian morphology through Ayurveda point of view.
2)To record the adverse effect of the treatment if any.  
During first two weeks. 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   05/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="10"
Days="15" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Both experimental and control groups are studied, respectively, and observations and conclusions are drawn from statistical tests for significance. 
Close